U.S. flag

An official website of the United States government

NM_005591.4(MRE11):c.1792G>C (p.Gly598Arg) AND Ataxia-telangiectasia-like disorder

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 2, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001345107.7

Allele description [Variation Report for NM_005591.4(MRE11):c.1792G>C (p.Gly598Arg)]

NM_005591.4(MRE11):c.1792G>C (p.Gly598Arg)

Gene:
MRE11:MRE11 homolog, double strand break repair nuclease [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q21
Genomic location:
Preferred name:
NM_005591.4(MRE11):c.1792G>C (p.Gly598Arg)
HGVS:
  • NC_000011.10:g.94445885C>G
  • NG_007261.1:g.52990G>C
  • NM_001330347.2:c.1789G>C
  • NM_005590.4:c.1783+1334G>C
  • NM_005591.4:c.1792G>CMANE SELECT
  • NP_001317276.1:p.Gly597Arg
  • NP_005582.1:p.Gly598Arg
  • NP_005582.1:p.Gly598Arg
  • LRG_85t1:c.1792G>C
  • LRG_85:g.52990G>C
  • LRG_85p1:p.Gly598Arg
  • NC_000011.9:g.94179051C>G
  • NM_005591.3:c.1792G>C
Protein change:
G597R
Links:
dbSNP: rs587781951
NCBI 1000 Genomes Browser:
rs587781951
Molecular consequence:
  • NM_005590.4:c.1783+1334G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001330347.2:c.1789G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005591.4:c.1792G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Ataxia-telangiectasia-like disorder (ATLD)
Identifiers:
MONDO: MONDO:0011457; MedGen: C1858391; OMIM: PS604391

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001539206Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Feb 2, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001539206.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with MRE11A-related conditions. ClinVar contains an entry for this variant (Variation ID: 216609). This sequence change replaces glycine with arginine at codon 598 of the MRE11A protein (p.Gly598Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024